CTOs on the Move

Ampersand Health

www.ampersand-health.com

 
Ampersand Health is developing markets, opening clinics and implementing proprietary workflows through investment in the most powerful and efficient mechanism for improving health and reducing costs - primary care. Ampersand Health tailors its solutions for health plans operating in inner city markets serving Medicare Advantage, Managed Medicaid and Dual Eligible members.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Ampersand Health raised $20M on 06/14/2016

Similar Companies

Stratum Health System

Stratum Health System is a nonprofit, integrated network providing care and support to people facing chronic or advanced illness. The Stratum family of companies helps patients live as comfortably and meaningfully as possible and offers assistance to their families and caregivers along the way. As their illness advances, Stratum offers a layer of medical and emotional support services that provides compassionate care across the continuum.

Carolina Clinical Research

Carolina Clinical Research is a Belews Creek, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Harborview Health Care

Harborview Health Care is a Morehead City, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mission Athletecare

MISSION is the first and only line of athlete-engineered products designed to enhance performance in training and competition. Co-founded in 2009 by a premier group of world-class athletes including Serena Williams, Dwyane Wade, Sergio Garcia, David Wright, Reggie Bush and Mia Hamm, MISSION boasts more than 25 high-performance product innovations and is sold in nearly 20,000 stores across the U.S. MISSION works with its world-renowned athletes, doctors and scientists to engineer products that help athletes prepare, perform and rehab from training or competition.

Dimension Therapeutics

Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.